INTRODUCTION
Ferric maltol is an oral iron complex composed of ferric iron (Fe³⁺) chelated with maltol, designed to improve iron absorption while reducing common gastrointestinal side effects associated with traditional iron salts. It is primarily used in the management of iron deficiency with better tolerability.
MANUFACTURE
Ferric maltol is manufactured by complexing ferric iron salts with maltol under controlled aqueous conditions, followed by purification and drying to obtain a stable iron–maltol complex. The process ensures consistent chelation, optimal iron content, and high product purity suitable for pharmaceutical use.
| Synonym(s) | Iron(III) 2-methyl-4-oxo-4H-pyran-3-olate |
| CAS no. | 33725-54-1 |
| Molecular formula | C18H15FeO9 |
| Molecular weight | 431.2 |
| Structure | ![]() |
APPLICATIONS
Primarily used for the management of iron deficiency. Its key applications include:
| Treatment of iron deficiency anemia (IDA): |
| Used in adults who cannot tolerate or do not respond well to conventional oral iron salts (such as ferrous sulfate). |
| Inflammatory bowel disease (IBD) patients: |
| Particularly beneficial in patients with Crohn’s disease or ulcerative colitis, as it has better gastrointestinal tolerability and minimal mucosal irritation. |
| Chronic iron deficiency conditions: |
| Suitable for long-term iron supplementation in conditions requiring sustained iron replacement, including chronic blood loss or malabsorption. |
| Patients requiring improved compliance: |
| Due to fewer gastrointestinal side effects (nausea, constipation, abdominal pain), ferric maltol improves adherence compared to traditional iron therapies. |
| Pharmaceutical formulations: |
| Used in oral solid dosage forms such as capsules and tablets for prescription iron therapy. |
SPECIFICATIONS
| Test | Unit | Specification |
|---|---|---|
| Description | – | Dark red to deep Brown, free flowing powder |
| Solubility | – | Freely soluble in dichloromethane, sparingly soluble in wáter |
| Identification | – | a. Positive for Iron b. Absorbance maxima is about 274 NM |
| pH (of 5% w/v aqueous solution) | – | 6.0 – 9.0 |
| Water content (by KF) | % w/w | NMT 6.0 |
| Arsenic | ppm | NMT 2.0 |
| Heavy metal (as Pb) | ppm | NMT 20.0 |
| Copper | ppm | NMT 30.0 |
| Zinc | ppm | NMT 30.0 |
| Chloride (on anhydrous basis) | w/w | NMT 3.0 |
| Maltol content by HPLC (on anhydrous basis) | w/w | NLT 80.0 |
| Related substance by HPLC a. Any unspecified impurity b. Total impurities | % % | NMT 0.1 NMT 0.5 |
| Iron content (on anhydrous basis) | % w/w | NLT 11.0 |
| Total microbial count | CFU/gm | NMT 1000 |
| Yeasts & Mould | CFU/gm | NMT 100 |
| Salmonella | – | Should be absent per 10 gm |
| E.Coli | – | Should be absent per gm |
| Staphylococcus aureus | – | Should be absent per gm |
| Pseudomonas aeruginosa | – | Should be absent per gm |
PACKING
25 kg HDPE drum
STORAGE
Store in a cool, dry place at room temperatures. Reclose packaging immediately after use.
CERTIFICATION
US-DMF available.
ExSyn offers Ferric maltol on commercial scales and welcomes enquiries. Our exceptional quality and service will make ExSyn your supplier of choice! If you need any additional information or SDS, please contact us.
Yttrium oxide (Y2O3), also known as yttria, is an air-stable, odorless white powder. It is a highly stable, chemically inert ceramic with a very high melting point. It is insoluble in water but readily dissolves in most strong acids. Increasing the specific surface area and porosity of Y2O3 can further improve its relevant physical and chemical properties.
Ethyl 7,7,7-trifluoro-3-hydroxy-3-methylheptanoate is a fluorinated aliphatic hydroxy ester. The presence of the trifluoromethyl group imparts enhanced metabolic stability, lipophilicity, and unique physicochemical properties compared with non-fluorinated analogues. This compound is primarily used as a synthetic intermediate in pharmaceutical and agrochemical research.
2-Chloro-1,1,1-trimethoxyethane is an organochlorine orthoester compound commonly used as a versatile synthetic intermediate in organic and pharmaceutical chemistry. It is a colorless to pale yellow liquid with good reactivity toward nucleophilic substitution and cyclization reactions, making it valuable in the preparation of heterocyclic and bioactive molecules.
Glycolaldehyde dimer is the cyclic dimeric form of glycolaldehyde, the simplest hydroxyaldehyde. Glycolaldehyde is often supplied as stable dimeric solid, commonly identified as 2,5-dihydroxy-1,4-dioxane.
N,N-Diisopropylethylamine (DIPEA), also known as Hünig’s Base, is a sterically hindered tertiary amine. It is a colorless liquid with a strong amine odor and is widely used as a low nucleophilic organic base in pharmaceutical, agrochemical, and fine chemical synthesis. Due to its bulky structure, DIPEA effectively scavenges acids without participating in unwanted side reactions.
Tris(2,4-di-tert-butylphenyl) phosphite (TDPP) often recognized commercially as Irgafos 168 is a high-performance organophosphorus compound primarily utilized as secondary antioxidant and processing stabilizer. Its characteristic to undergo metallation reaction and provide a cost-effective synthetic processes allows it to be useful in biaryl coupling reactions.
Undecylenic acid is an unsaturated fatty acid naturally derived from castor oil. It is a colorless to pale yellow liquid with antifungal and antimicrobial properties. Chemically known as 10-undecenoic acid, it contains an 11-carbon chain with one double bond and is widely used in pharmaceuticals
5-Nitro Isophthalic Acid (5-NIPA) is an aromatic organic compound derived from isophthalic acid. The presence of two carboxylic acid groups along with a nitro substituent at the 5-position makes it a valuable intermediate in the manufacture of fine chemicals, pharmaceuticals, dyes, pigments, and advanced materials.
Trichloroacetonitrile is a halogenated organic compound belonging to nitrile family. Its strong electrophilic character makes it a valuable intermediate in organic synthesis. It readily undergoes hydrolysis, particularly under acidic or basic conditions, yielding trichloroacetamide and related derivatives.
